Redmond Asset Management LLC Has $1,108,000 Stake in Danaher Corporation (DHR)

Redmond Asset Management LLC maintained its stake in Danaher Corporation (NYSE:DHR) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 14,236 shares of the conglomerate’s stock at the end of the first quarter. Redmond Asset Management LLC’s holdings in Danaher Corporation were worth $1,108,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the company. Parnassus Investments CA raised its stake in Danaher Corporation by 15.3% in the first quarter. Parnassus Investments CA now owns 8,622,528 shares of the conglomerate’s stock valued at $712,738,000 after buying an additional 1,143,284 shares during the period. Bank of New York Mellon Corp increased its position in shares of Danaher Corporation by 0.7% in the first quarter. Bank of New York Mellon Corp now owns 7,645,818 shares of the conglomerate’s stock valued at $653,946,000 after buying an additional 50,673 shares in the last quarter. Flossbach Von Storch AG increased its position in shares of Danaher Corporation by 6.2% in the first quarter. Flossbach Von Storch AG now owns 3,996,209 shares of the conglomerate’s stock valued at $341,796,000 after buying an additional 234,770 shares in the last quarter. First Manhattan Co. increased its position in shares of Danaher Corporation by 0.8% in the first quarter. First Manhattan Co. now owns 2,932,760 shares of the conglomerate’s stock valued at $229,899,000 after buying an additional 22,098 shares in the last quarter. Finally, Findlay Park Partners LLP increased its position in shares of Danaher Corporation by 28.1% in the first quarter. Findlay Park Partners LLP now owns 2,692,348 shares of the conglomerate’s stock valued at $230,277,000 after buying an additional 590,000 shares in the last quarter. Hedge funds and other institutional investors own 76.12% of the company’s stock.

Danaher Corporation (NYSE DHR) traded down 0.05% during mid-day trading on Friday, reaching $80.87. 2,861,306 shares of the company were exchanged. The company has a 50 day moving average of $82.32 and a 200-day moving average of $84.22. The company has a market capitalization of $56.18 billion, a price-to-earnings ratio of 25.81 and a beta of 1.03. Danaher Corporation has a 1-year low of $75.71 and a 1-year high of $88.01.

Danaher Corporation (NYSE:DHR) last released its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.97 by $0.02. The business had revenue of $4.51 billion for the quarter, compared to the consensus estimate of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The business’s revenue was up 6.3% on a year-over-year basis. During the same period in the previous year, the firm earned $0.90 EPS. On average, equities research analysts forecast that Danaher Corporation will post $3.95 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This piece of content was posted by BNB Daily and is the sole property of of BNB Daily. If you are viewing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark law. The original version of this piece of content can be viewed at https://www.baseball-news-blog.com/2017/08/20/redmond-asset-management-llc-continues-to-hold-stake-in-danaher-corporation-dhr-updated-updated-updated.html.

Several research analysts have commented on the stock. Royal Bank Of Canada reissued a “sector perform” rating and set a $88.00 price objective (down previously from $89.00) on shares of Danaher Corporation in a report on Friday, April 21st. BidaskClub downgraded shares of Danaher Corporation from a “hold” rating to a “sell” rating in a report on Tuesday, July 25th. Zacks Investment Research downgraded shares of Danaher Corporation from a “buy” rating to a “hold” rating in a report on Thursday, July 27th. Citigroup Inc. set a $96.00 price objective on shares of Danaher Corporation and gave the company a “buy” rating in a report on Friday, July 21st. Finally, Janney Montgomery Scott downgraded shares of Danaher Corporation from a “buy” rating to a “neutral” rating in a report on Wednesday, June 7th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. Danaher Corporation has a consensus rating of “Buy” and an average target price of $91.76.

In other news, insider William King sold 7,458 shares of the business’s stock in a transaction that occurred on Friday, July 21st. The shares were sold at an average price of $82.97, for a total value of $618,790.26. Following the sale, the insider now directly owns 18,245 shares of the company’s stock, valued at approximately $1,513,787.65. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the business’s stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $81.78, for a total transaction of $799,154.16. Following the completion of the sale, the insider now directly owns 155,520 shares in the company, valued at $12,718,425.60. The disclosure for this sale can be found here. Insiders sold a total of 38,623 shares of company stock worth $3,206,426 over the last three months. Insiders own 12.20% of the company’s stock.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply